Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BERLIN and Nevada, May 5, 2014 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Entry Standard, XETRA: MF6), a leading medical device company in the field of nanomedicine focused on oncology, together with...
-
BERLIN, March 31, 2014 (GLOBE NEWSWIRE) -- Dear MagForce Shareholders, I am pleased to report that we achieved our 2013 targets and are progressing well toward achieving our objectives for the year...
-
BERLIN, March 31, 2014 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra: MF6), a leading medical technology company in the area of nanotechnology which focuses on oncology, today announced the...
-
Berlin, Germany, Dec. 19, 2013 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra:MF6), a medical technology company that focuses on the field of oncology and is a leader in the nanotechnology sector,...
-
BERLIN, Nov. 8, 2013 (GLOBE NEWSWIRE) -- Dear MagForce Shareholders, I am pleased to report that we are on target to achieve our 2013 plans: Brain Cancer Therapy: Our main objective for 2013 is to...
-
BERLIN, Germany, Nov. 6, 2013 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra: MF6), a medical technology company that focuses on the field of oncology and is a leader in the nanotechnology sector,...
-
BERLIN, Germany, Oct. 22, 2013 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra: MF6), a leading medical device company in the area of nanotechnology with a focus on oncology, today announced...
-
BERLIN, Sept. 30, 2013 (GLOBE NEWSWIRE) -- * Capital increase of €33.5 million successfully completed * New glioblastoma study approved by BfArM * Ben J. Lipps new Chairman of the...